Affimed N.V. (AFMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AFMD | AZN | AMGN | GILD | BMY |
| Company | Affimed N.V. | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.2175 | 199.40 | 375.18 | 146.32 | 61.80 |
| High | 0.2370 | 199.52 | 377.09 | 146.75 | 62.00 |
| Low | 0.1721 | 197.56 | 369.50 | 144.02 | 60.73 |
| Latest | 0.1815 | 198.65 | 371.68 | 145.07 | 61.50 |
| Change | -0.0975 | -2.88 | -7.59 | -3.15 | -0.83 |
| % Change | -34.95% | -1.43% | -2.00% | -2.13% | -1.33% |
| Volume | 23,468,000 | 690,604 | 333,480 | 767,007 | 1,970,703 |
| 20-Day Average Volume | 48,606,074 | 2,322,034 | 2,692,474 | 7,520,250 | 13,213,533 |
| Previous Close | 0.2790 | 201.53 | 379.27 | 148.22 | 62.33 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6772 | 202.12 | 376.33 | 150.10 | 60.95 |
| 20-Day Raw Stochastic | 10.51% | 44.58% | 38.23% | 11.27% | 58.02% |
| 20-Day Relative Strength | 32.05 | 52.02 | 55.42 | 52.57 | 58.13 |
| Weighted Alpha | -87.64 | +34.81 | +24.22 | +31.63 | +13.58 |
| Today's Opinion | 100% Sell | 88% Buy | 88% Buy | 88% Buy | 100% Buy |
| Previous Opinion | 100% Sell | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 72% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -73.81% since 05/12/25 | -2.56% since 02/26/26 | -1.78% since 02/26/26 | +0.64% since 02/26/26 | +0.44% since 02/26/26 |
| Low | 0.0701 on 05/15/25 | 197.10 on 03/03/26 | 370.63 on 03/05/26 | 143.37 on 02/27/26 | 60.43 on 03/03/26 |
| High | 0.5733 on 05/16/25 | 209.93 on 02/27/26 | 391.29 on 03/02/26 | 150.77 on 03/02/26 | 62.89 on 03/02/26 |
| 1-Month | |||||
| %Chg | -75.26% since 04/17/25 | +6.20% since 02/05/26 | +1.30% since 02/05/26 | -3.13% since 02/05/26 | +3.11% since 02/05/26 |
| Low | 0.0701 on 05/15/25 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 143.09 on 02/26/26 | 59.23 on 02/19/26 |
| High | 1.1300 on 05/01/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -82.88% since 02/19/25 | +10.20% since 12/05/25 | +12.94% since 12/05/25 | +19.36% since 12/05/25 | +17.68% since 12/05/25 |
| Low | 0.0701 on 05/15/25 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.33 on 12/10/25 |
| High | 1.1300 on 05/01/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -93.95% since 11/19/24 | +21.64% since 09/05/25 | +31.36% since 09/05/25 | +25.76% since 09/05/25 | +30.19% since 09/05/25 |
| Low | 0.0701 on 05/15/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 3.0982 on 11/25/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,922 | 312,554,496 | 204,452,320 | 184,003,424 | 126,933,432 |
| Shares Outstanding, K | 16,100 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 8,960,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -114,660,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 170,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -16,650,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.07 | 0.32 | 0.45 | 0.37 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/14/24 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 06/11/25 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 22.03 | 17.25 | 18.14 | 9.95 |